Sosei Group: Notice of Change of Corporate Name to Nxera : v

Tokyo, Japan and Cambridge, UK, 16 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), today announces that at a...

Related Keywords

Japan , Chiyoda Ku , Tokyo , Cambridge , Cambridgeshire , United Kingdom , Japanese , Sosei Heptares , Akasaka Minato Ku , Kentaro Tahara , Shinichiro Nishishita , Frazer Hall , Maya Bennison , Nxera Pharma Kabushiki Kaisha , Erica Hollingsworth , Board Of Directors Sosei Co , Sosei Co , Sosei Group Kabushiki Kaisha , Nxera Pharma Japan Co Ltd , Sosei Group Corporation Heptares , Heptares Therapeutics Ltd , Idorsia Pharmaceuticals Korea Co Ltd , Nxera Pharma Korea Co Ltd , Medistrava Consulting For International Media , Idorsia Pharmaceuticals Japan Ltd , Head Office Of The Company , Sosei Group Corporation , Nxera Pharma United Kingdom , Nxera Pharma Co Ltd , Head Office , Board Of Directors The Company , Ordinary General Meeting , Merger Agreement , Corporate Name , Group Kabushiki Kaisha , Pharma Kabushiki Kaisha , Supplementary Provisions , Corporate Strategy , International Media , Japan Exchange Group 4565 T , Pcr , Dharma , Iopharma ,